Health
Targeting BCAP with new drugs could benefit people with inflammatory bowel disease – News-Medical.Net
Managing the activity of the BCAP protein could help the body repair intestinal tissue from damage caused by inflammation, according to a new study led by experts…
Reviewed by Emily Henderson, B.Sc.Nov 17 2020
Managing the activity of the BCAP protein could help the body repair intestinal tissue from damage caused by inflammation, according to a new study led by experts at Cincinnati Children’s.
The findings, published online Nov. 16, 2020, in PNAS, suggest that targeting BCAP with new medications could benefit people living with conditions such as inflammatory bowel disease (IBD).
The multi-center research team was led by first author Ricardo Irizarry-Caro,…
-
Business15 hours agoBattle of the ASX ETFs: Why has VGS outperformed VTS this year?
-
General24 hours agoLiberals dump NSW candidate who said women should not serve in ADF combat
-
Business11 hours ago1 ASX dividend stock down 43% I’d buy right now
-
General21 hours agoCoalition abandons ‘end’ to work from home, walks back 41,000 job cuts